Egyptian Financial Group Hermes Holding (EFG Hermes) (HRHO) is currently working on about five initial public offerings (IPOs), Co-Head of Investment Banking at EFG Hermes Mostafa Gad told Al Borsa Newspaper.
These IPOs include Macro Group Pharmaceutical, Abu Auf, and Ebtikar, in addition to, two offering for the private sector, Gad said.
Three companies are expected to be offered on the Egyptian Exchange (EGX) in the first half (H1) of 2022 if liquidity ratios continued improvement after e-finance’s IPO, he pointed out.
The other two offerings could be implemented in H2 2022 as they provide a different business model from its peers in the Egyptian market, Gad added.
Moreover, he revealed that the company is working on three new offerings on the Saudi Stock Market (Tadawul) that are likely to be completed by the end of 2021 or in early 2022.
Additionally, EFG Hermes is working on two new offerings on the Abu Dhabi Securities Exchange (ADX) that are expected to be closed by the beginning of 2022, he said.
The company also aims to close three acquisition deals in Saudi Arabia, of which one is in the healthcare sector and is likely to be completed before the end of 2021.
Furthermore, he revealed that EFG Hermes is getting ready to close three deals in the Egyptian market before the end of 2021, including SODIC deal, as well as two transactions in the UAE.
Last week, the company announced it completed advisory to ACWA Power on its IPO valued at SAR 4.5 billion ($1.2 billion) on Tadawul.
In 2021, EFG Hermes’ banking division previously served as joint bookrunner on the AED 4 billion listing of ADNOC Drilling on the Abu Dhabi Securities Exchange (ADX), as well as on the AED 2.7 billion listing of Yahsat on the ADX.
EFG Hermes has presence in the UAE, Saudi Arabia, Kuwait, Jordan, Oman, and Pakistan. It operates in holding and treasury, brokerage, asset management, investment banking, private equity, leasing, microfinance, and assets held for sale.
